Dermatological and endocrine elements in Carney complex (Review).

Area of Science:

• Endocrinology
• Genetics
• Dermatology

Background:

• Carney complex (CNC) is a rare autosomal dominant hereditary syndrome.
• Mutations in the PRKAR1A gene (CNC1) are found in 70% of individuals, with 30% having phosphodiesterase gene mutations.
• CNC is part of the lentiginosis family, presenting with dermatological features like skin pigmentation and myxomas.

Purpose of the Study:

• To provide a comprehensive overview of Carney complex (CNC).
• To highlight the diverse clinical manifestations and genetic basis of CNC.
• To emphasize the importance of early dermatological detection for this systemic condition.

Main Methods:

• Review of existing literature on Carney complex.
• Analysis of genetic mutations associated with CNC (PRKAR1A, phosphodiesterase genes).
• Compilation of clinical features including dermatological, endocrine, and neoplastic manifestations.

Main Results:

• Dermatological features include lentigines, cutaneous/mucosal myxomas, epithelioid blue nevi, and pigmented epithelioid melanocytoma.
• Endocrine involvement comprises pituitary adenomas (corticotropinomas, somatotropinomas), primary pigmented nodular adrenocortical disease causing Cushing syndrome, and thyroid abnormalities.
• Neoplastic risks include Sertoli cell tumors in males and specific mammary tumors.

Conclusions:

• Carney complex is a multi-system disorder with significant dermatological and endocrine involvement.
• Early diagnosis is facilitated by recognizing cutaneous lesions, which are often the earliest signs.
• Genetic testing and comprehensive screening are essential for managing CNC patients.